NP3 A COST-UTILITY MODEL OF TREATMENT OF NEWLY DIAGNOSED EPILEPSY IN GERMANY COMPARING TOPIRAMATE, CARBAMAZEPINE AND VALPROATE
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65684-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)65684-7/fulltext
Title :
NP3 A COST-UTILITY MODEL OF TREATMENT OF NEWLY DIAGNOSED EPILEPSY IN GERMANY COMPARING TOPIRAMATE, CARBAMAZEPINE AND VALPROATE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65684-7&doi=10.1016/S1098-3015(10)65684-7
First page :
Section Title :
Open access? :
No
Section Order :
53